STOCK TITAN

Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Bausch Health (NYSE:BHC) announced that management will participate in a fireside chat at the Barclays 30th Annual Leveraged Finance Conference in Austin, Texas on Tuesday, May 19, 2026 at 10:25 a.m. U.S. ET.

A live webcast and replay will be available on the company’s investor relations website.

Loading...
Loading translation...

AI-generated analysis. Not financial advice.

Positive

  • None.

Negative

  • None.

News Market Reaction – BHC

-2.22%
1 alert
-2.22% News Effect

On the day this news was published, BHC declined 2.22%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Conference edition: 30th Annual Conference date: May 19, 2026 Chat time: 10:25 a.m. U.S. ET
3 metrics
Conference edition 30th Annual Barclays Leveraged Finance Conference
Conference date May 19, 2026 Barclays Leveraged Finance Conference participation
Chat time 10:25 a.m. U.S. ET Scheduled fireside chat start time

Market Reality Check

Price: $5.16 Vol: Volume 1,970,615 is sligh...
normal vol
$5.16 Last Close
Volume Volume 1,970,615 is slightly above the 20-day average of 1,801,557 (relative volume 1.09) ahead of the conference update. normal
Technical Shares at $5.37 are trading below the 200-day MA of $6.34, and about 38.17% below the 52-week high.

Peers on Argus

BHC is down 6.61% while 4 of 5 high-affinity peers (HCM, INDV, SUPN, AMRX) also ...

BHC is down 6.61% while 4 of 5 high-affinity peers (HCM, INDV, SUPN, AMRX) also trade lower; only ALVO is positive (+5.28%), suggesting broader pressure in specialty/generic pharma rather than conference-specific impact.

Historical Context

5 past events · Latest: Apr 29 (Neutral)
Pattern 5 events
Date Event Sentiment Move Catalyst
Apr 29 Q1 2026 earnings Neutral +2.3% Reported higher revenue with major goodwill impairment and reaffirmed 2026 guidance.
Apr 14 Product launch Positive -0.7% U.S. online launch of Biafine Skin Recovery Emulsion via multiple channels.
Mar 31 Earnings date set Neutral +7.4% Announced date and time for first quarter 2026 financial results and call.
Mar 26 Scholarship program Positive +0.8% Launched 2026 ASPIRE HIGHER scholarships up to $10,000 each for six students.
Feb 23 Device launch Positive -2.5% Introduced Clear + Brilliant Touch laser in Canada after Health Canada approval.
Pattern Detected

Recent company news has generally produced modest single‑digit price moves, with limited follow‑through after operational or corporate updates.

Recent Company History

This announcement continues a pattern of investor‑relations focused communication. In late March 2026, Bausch Health pre‑announced its Q1 results date, which saw a 7.36% move. The subsequent Q1 2026 earnings release on April 29 showed revenue of $2.52 billion with a large goodwill impairment but a 2.33% gain, while product and program news (scholarships, launches) around February–April drove smaller, mixed reactions between roughly -2.45% and 0.79%. Today’s conference participation fits that lower‑impact category of news.

Market Pulse Summary

This announcement highlights Bausch Health’s participation in the Barclays leveraged finance confere...
Analysis

This announcement highlights Bausch Health’s participation in the Barclays leveraged finance conference, offering management a platform to address investors on capital structure and strategy. It follows recent Q1 2026 results, including revenue of $2.52 billion and a large goodwill impairment, as detailed in recent filings. Investors may watch for any new qualitative commentary from the May 19, 2026 fireside chat that elaborates on guidance, debt profile, or pipeline priorities.

Key Terms

leveraged finance, webcast
2 terms
leveraged finance financial
"Participate in a fireside chat at the Barclays 30th Annual Leveraged Finance Conference"
Leveraged finance is the use of large amounts of borrowed money, often through high-yield bonds or loans, to fund big moves like buyouts, acquisitions, or major restructuring. It matters to investors because the higher borrowing raises a company’s fixed payments and default risk — similar to a person taking a big mortgage to buy a house — which can amplify both potential returns and losses and influence a firm’s stock and bond safety.
webcast technical
"A live audio webcast of the event will be accessible on the Investor Relations section"
A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.

AI-generated analysis. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

LAVAL, QC, May 12, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that members of company management will participate in a fireside chat at the Barclays 30th Annual Leveraged Finance Conference in Austin, Texas on Tuesday, May 19, 2026. A live audio webcast of the event will be accessible on the Investor Relations section of Bausch Health's website.

Details

Date:           Tuesday, May 19, 2026

Time:           10:25 a.m. U.S. ET

Webcast:     http://ir.bauschhealth.com/events-and-presentations

A replay of the event will be available on the investor relations website following the event.

About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information about Bausch Health, visit www.bauschhealth.com and connect with us on LinkedIn.

Forward-looking Statements
This news release may contain forward-looking statements within the meaning of applicable securities laws, including the Safe Harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995.  Forward-looking statements may generally be identified by the use of the words "will," "anticipates," "hopes," "expects," "intends," "plans," "should," "could," "would," "may," "believes," "subject to" and variations or similar expressions. These statements are neither historical facts nor assurances of future performance, are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Actual results are subject to other risks and uncertainties that relate more broadly to Bausch Health's overall business, including those more fully described in Bausch Health's most recent annual and quarterly reports and detailed from time to time in Bausch Health's other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference.  Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. The Company undertakes no obligation to update any of these forward-looking statements to reflect events, information or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.

Investor Contact:

 Media Contact:

Garen Sarafian

 Katie Savastano

ir@bauschhealth.com

corporate.communications@bauschhealth.com

(877) 281-6642 (toll free)

(908) 569-3692



BHC-FINANCIAL


Bausch Health logo (PRNewsfoto/Bausch Health Companies Inc.)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bausch-health-to-participate-in-barclays-30th-annual-leveraged-finance-conference-302770033.html

SOURCE Bausch Health Companies Inc.

FAQ

When will Bausch Health (BHC) present at the Barclays 30th Annual Leveraged Finance Conference?

Bausch Health will present at the Barclays 30th Annual Leveraged Finance Conference on Tuesday, May 19, 2026, at 10:25 a.m. U.S. ET. According to the company, the session features a fireside chat with management in Austin, Texas.

How can investors access the Bausch Health (BHC) webcast from the Barclays 2026 Leveraged Finance Conference?

Investors can access Bausch Health’s live audio webcast via the investor relations section of its website. According to the company, the webcast link is available under events and presentations, with a replay posted on the same investor relations page afterward.

Will a replay of Bausch Health’s (BHC) Barclays 30th Annual Leveraged Finance Conference presentation be available?

Yes, a replay of Bausch Health’s conference fireside chat will be available on its investor relations website. According to the company, the replay can be accessed after the live event under the events and presentations section.